2 Wegovy is available on the NHS for adults with: A BMI of 35 or higher (32.5 or higher for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) At least one weight-related condition (type 2 diabetes, hypertension, cardiovascular disease, obstructive sleep apnoea, or dyslipidaemia) Referral to and engagement with a specialist weight management service (Tier 3) NICE caps NHS treatment with Wegovy at two years
Most side-effect-driven discontinuations in STEP-1 happened in the first 20 weeks [1]
Documents that control The member's exact plan-year formulary, evidence of coverage, and prior-authorization policy Why answers differ Employer choices, state market, plan type, and benefit year can all change coverage Sources: How the BCBS system is organized
Regular assessment by the bariatric surgery team ensures anatomical integrity, identifies potential surgical complications, and monitors for nutritional deficiencies